| Analyst | Price Target | Date |
|---|---|---|
| Redeye | 5.5 SEK | Aug -25 |
| DNB | 2 SEK | Feb -25 |
| DNB Markets | 5.5 SEK | Jun -24 |
| Carnegie | 6.8 SEK | Nov -23 |
| ABG Sundal Collier | 12 SEK | Sep -22 |
| Kempen | 35 SEK | Jul -22 |
| SEB Equities | 0.35 SEK | Oct -21 |
Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode’s shares have been listed on the Stockholm Stock Exchange’s main list since 2017.
Wikipedia